Cancers

Cancers (Basel) · ISSN (print) 2072-6694 · 349 papers in corpus
2026
doi:10.3390/cancers18091485 ·PMID:42122280

Background: Accurate colposcopy assessment is essential for detection of cervical precancerous lesions. However, the diagnostic performance depends heavily on the examiner's experience and subjective interpretation. Recent advances in artif…

2026
doi:10.3390/cancers18071051 ·PMID:41976274

Background/objectivesEndometrial cancer (EC) is a multifactorial disease influenced by metabolic, hormonal, and environmental factors. Trace and macroelements play a critical role in cellular homeostasis, oxidative stress, and tumor progres…

2026
doi:10.3390/cancers18081252 ·PMID:42073577

Background/Objectives: Depot medroxyprogesterone acetate (dMPA) is a synthetic progestin commonly used for contraception. Recent studies have reported an increased association between dMPA exposure and diagnosis of cerebral meningioma. The …

review 2026
doi:10.3390/cancers18081312 ·PMID:42073634

Early diagnosis of ovarian cancer remains one of the most important unmet needs in gynecologic oncology because survival is strongly stage-dependent and most patients still present with disseminated disease. Conventional non-invasive tools,…

2026
doi:10.3390/cancers18060960 ·PMID:41899562

Background/objectivesGiven its cost-effectiveness and availability, NLR could play a pivotal role in refining the diagnostic process. We aimed to evaluate whether NLR can serve as a useful marker to differentiate between benign and malignan…

2026
doi:10.3390/cancers18081290 ·PMID:42073613

Persistent post-endometrial ablation uterine bleeding indicates that no method of EA eliminates the entire endometrium, and post-EA hysteroscopy shows a distorted and scarred uterine cavity in the majority of patients. These observations ra…

2026
review 2026
doi:10.3390/cancers18081233 ·PMID:42073558

Endometriosis is a chronic estrogen-dependent disorder affecting approximately 10% of women of reproductive age. Increasing epidemiological and molecular evidence indicates that it may represent a precursor condition for a subset of ovarian…

2026
doi:10.3390/cancers18030484 ·PMID:41681957

Background/Objectives: Ovarian cancer (OC) remains one of the most lethal gynecological malignancies, mainly because it is frequently diagnosed at advanced stages due to nonspecific symptoms and the lack of effective screening strategies. L…

2026
doi:10.3390/cancers18061005 ·PMID:41899606

Endometrial cancer (EC) is the most common gynaecologic malignancy in developed countries, and its diagnostic and prognostic framework has evolved substantially following the introduction of the 2023 FIGO staging system, which integrates mo…

2026
doi:10.3390/cancers18091495 ·PMID:42122290

BackgroundAngiogenesis is critical for tumor progression. Microvessel density (MVD) is commonly assessed using CD31 and CD34, which detect both mature and newly formed vessels and therefore cannot distinguish active neoangiogenesis from sta…

2026
doi:10.3390/cancers18020283 ·PMID:41595201

Background/Objectives: Kidney cancer (RC) is a significant global health burden. Renal cell carcinoma (RCC) is the most common form of kidney cancer. Its predominant histological subtype is clear cell renal cell carcinoma (ccRCC), which is …

2026
doi:10.3390/cancers18111690 ·PMID:42279274

Ovarian cancer (OC) remains one of the most lethal gynaecological malignancies, which is mainly due to late diagnosis, high frequency of metastasis, and the risk of developing resistance to systemic therapy. In recent years, exosomes-small …

2026
doi:10.3390/cancers18010173 ·PMID:41514680

Background: Ovarian cancer is a leading gynecological malignancy with high global mortality. Early and accurate diagnosis is critical for optimal management; however, a considerable portion of ovarian masses remain indeterminate after initi…

2026
2026
2026
2026
doi:10.3390/cancers18030356 ·PMID:41681828

Endometrial cancer (EC) is the most common gynecological cancer in developed countries, with approximately 417,000 new cases reported worldwide in 2020. Its incidence has been rising for the past 30 years, primarily due to population aging,…

2026
2026
doi:10.3390/cancers18121935 ·PMID:42352470

BackgroundScar carcinoma represents a distinct subtype of lung malignancy developing in areas of chronic pulmonary fibrosis, inflammation, and structural remodeling, frequently associated with previous pulmonary tuberculosis (TB). The prese…

2025
doi:10.3390/cancers17162691 ·PMID:40867320

Background/Objectives: Flow cytometric analysis of cellular DNA content has prognostic importance in ovarian cancer and its measurement could contribute to clinical practice. The aim of this study was to compare serous cystadenoma and serou…

2025
doi:10.3390/cancers17183025 ·PMID:41008868

Sexual dysfunction (SD) and sexual health problems are common distressing and often under-addressed issues among both male and female patients with cancer and without cancer [...].

2025
doi:10.3390/cancers17233819 ·PMID:41375020

Bartholin gland carcinoma (BGC) is a rare malignancy, comprising 3-7% of vulvar cancers and <1% of gynecologic tumors. Due to its low incidence, high-level evidence is lacking, and management is largely extrapolated from vulvar cancer guide…

2025
doi:10.3390/cancers17172759 ·PMID:40940856

Background/objectivesHigh-grade serous carcinoma (HGSC) is the leading cause of ovarian cancer-related mortality. It usually arises from fallopian tube epithelium, with a smaller subset arising in non-tubal sites including the ovary or peri…

2025
doi:10.3390/cancers17243902 ·PMID:41463153

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, largely due to late-stage diagnosis and limited therapeutic efficacy. The carbohydrate antigen 19-9 (CA19-9) is the most widely used serum biomarker in the…